Revive Therapeutics (RVV.C), a company that specializes in creating treatments and tests for diseases that don’t have many existing options available, has made a deal with a health research…
Chris Parry
Just days after Tempus Resources (TMRR.V, though not for much longer) dropped a middling resource update and ‘big news’ that they were extending the option on a lithium property,…
Our sales guy was having a rough day. Markets down, and for quite some time. Lots of companies on their third month of saying, “maybe in a couple of…
We often consult with public company leadership teams about their strategy in talking to the market, and most CEOs we meet come in one of two extreme flavours. The…
About a week ago, we noted a company we’ve been watching for a while, Nicorp Developments (NB.T) had gone on a run. The run hadn’t coincided with any real…
Conventional wisdom in the junior mining world is, if your stock price isn’t ramping up, and the market isn’t giving love to anyone, the one thing to do in…
A few weeks back, in what has become a seminal Equity.Guru piece about the quickly legalizing safe supply drug space, I tore into PharmaDrug (PHRX.C), which was lurching into…
Back at the dawn of Covid-19, a load of public companies started pumping out news releases that claimed they were going to be entering the medical space. In the…
I remember the day Karim Rayani called me up and said, “I’ve got a plan for Marvel Resources (MARV.V) and I said, “Cool, okay, I guess,” and he got…
UPDATE: Niocorp has ripped a further $1+ since this article was posted, now sitting at $7 and showing the first signs of profit taking. We talked up Niocorp Developments…